EMA perspective on the value of model-informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding.
Efthymios ManolisFlora Tshinanu MusuambaCorinne S de VriesPieter J ColinMartin B OleksiewiczPublished in: CPT: pharmacometrics & systems pharmacology (2024)
Keyphrases